Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP956463.RALrI1o5YZoVG1_7h-nhXNdzbaRxMkMOIrIghg_q4oxKI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP956463.RALrI1o5YZoVG1_7h-nhXNdzbaRxMkMOIrIghg_q4oxKI130_assertion type Assertion NP956463.RALrI1o5YZoVG1_7h-nhXNdzbaRxMkMOIrIghg_q4oxKI130_head.
- NP956463.RALrI1o5YZoVG1_7h-nhXNdzbaRxMkMOIrIghg_q4oxKI130_assertion description "[Together, our findings suggest that selectively targeting tumor-elicited myeloid cells or versican represents a potential therapeutic strategy for combating metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP956463.RALrI1o5YZoVG1_7h-nhXNdzbaRxMkMOIrIghg_q4oxKI130_provenance.
- NP956463.RALrI1o5YZoVG1_7h-nhXNdzbaRxMkMOIrIghg_q4oxKI130_assertion evidence source_evidence_literature NP956463.RALrI1o5YZoVG1_7h-nhXNdzbaRxMkMOIrIghg_q4oxKI130_provenance.
- NP956463.RALrI1o5YZoVG1_7h-nhXNdzbaRxMkMOIrIghg_q4oxKI130_assertion SIO_000772 22282653 NP956463.RALrI1o5YZoVG1_7h-nhXNdzbaRxMkMOIrIghg_q4oxKI130_provenance.
- NP956463.RALrI1o5YZoVG1_7h-nhXNdzbaRxMkMOIrIghg_q4oxKI130_assertion wasDerivedFrom befree-2016 NP956463.RALrI1o5YZoVG1_7h-nhXNdzbaRxMkMOIrIghg_q4oxKI130_provenance.
- NP956463.RALrI1o5YZoVG1_7h-nhXNdzbaRxMkMOIrIghg_q4oxKI130_assertion wasGeneratedBy ECO_0000203 NP956463.RALrI1o5YZoVG1_7h-nhXNdzbaRxMkMOIrIghg_q4oxKI130_provenance.